Wegovy has more cardiovascular outcomes data from the SELECT trial, which is relevant if you have established cardiovascular disease
Novo alleges that because Hims compounded products contain semaglutide claimed in the 343 patent, their sale infringes its patent rights
[1] The MHRA, NICE and NHS provide comprehensive guidance on the safe prescribing and monitoring of GLP-1 agonists, emphasising the importance of patient education regarding expected side effects and warning signs that warrant medical attention
Reports include serious side effects such as nausea, vomiting, and even hospitalization due to incorrect dosing and mislabeled products
A balanced diet and exercise can help enhance the effectiveness of the medication and support long-term weight management
In fact, the path the Ozempic MDL is on is one that you want to avoid